Management team
Gyros senior management includes several team members with over 20-years experience in the areas of research and development, sales and marketing and business development. They have all held senior positions in small to multi-national companies and global organizations within the pharmaceutical, biotechnology, diagnostics and life science supply sectors.
Erik Walldén
CEO & President
Mr. Walldén has more than 20 years of executive management experience
and a record of achievements in the biotech and life science industries.
Until December 2008, he was President and CEO of Affibody Holding AB, which he restructured for near-term and sustained profitability. Prior to this, he was President and CEO of Biacore International AB, which, after a successful turnaround, was sold to GE Healthcare in 2006.
In 2000, Mr. Walldén led Pyrosequencing AB (now Biotage AB) through a successful IPO on OMX Stockholm. He has also been instrumental in establishing and growing companies such as PerSeptive Biosystems Inc. (now part of Life Technologies Inc.), Pharmacia Biosensor AB, and Pharmacia Biotech (both now part of GE Healthcare Life Sciences).
He serves on the boards of the Industrial Supervisory Board of Healthinvest Partners AB, Exiqon A/S, Tecan Group Ltd. and chairs the Business and Finance Work Group at Sweden BIO.
Mr. Walldén is a Chemical Engineer with studies in analytical chemistry and biochemistry at Uppsala University.
Mathias Brandhammar
CFO & VP Business Support
As CFO & VP Business Support Mr Brandhammar is also Secretary of the Board for Gyros AB and Company Secretary for Gyros subsidiaries outside of Sweden.
Mr Brandhammar began his career as Accounting Manager with Fridhem AS/Tunga Reservdelar AB where he was responsible for finance and administration. He moved to the former Pharmacia Biotech AB in 1992 where, during the following years, he held several senior financial management and administrative positions.
Before joining Gyros, Mr Brandhammar was Global Director for R&D Finance and Administration within Amersham Pharmacia Biotech (now GE Healthcare).
Katherine Flagg
VP Global Sales & US Operations
Ms. Flagg joined Gyros in 2009. She has vast experience in leading sales, service and application teams in the biotech supply industry.
Ms. Flagg began her career in life sciences at Pharmacia Biotech (now GE Healthcare) in 1988 and has since then successfully held several key roles in sales and market development at BioVeris/IGEN, ForteBio and most recently at BioScale. Her in-depth knowledge of the process involved in the development of protein therapeutics is of significant value for researchers who employ Gyrolab technology to accelerate their drug development process. Helping customers identify and implement relevant new tools that bring value to their research is the focus of her efforts.
Jon-Sverre Schanche
VP Technical Affairs
Dr. Schanche has almost thirty years of industrial R&D and management experience. Most recently, he was Vice President R&D at DAKO Denmark A/S where he established a system development organization for in vitro diagnostic products. Before this, he held executive roles within the drug discovery and biotechnology supply industry, including Vice President of R&D in Personal Chemistry AB and Biotage AB and several senior management positions in Amersham Pharmacia Biotech (now GE Healthcare), including General Manager for the Norwegian R&D site.
Dr. Schanche has a Ph.D. in biochemistry from the University of Bergen, Norway.